Novel strategies to retard renal disease progression: combining ACE inhibition with endothelin receptor blocking?
Benigni
A
A
Remuzzi
G
G
D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000502:physiology; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D000804:Angiotensin II